Sarcopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Sarcopenia pipeline market research report provides comprehensive information on the therapeutics under development for sarcopenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sarcopenia and features dormant and discontinued projects.
Key Targets in the Sarcopenia Pipeline Market
The key targets in the sarcopenia pipeline market are Androgen Receptor, Chloride Channel Protein, Glucagon Like Peptide 1 Receptor, Growth/Differentiation Factor, Indoleamine 2,3 Dioxygenase, and Leucine Rich Repeat Containing G Protein Coupled Receptor 4. Androgen Receptor has the highest number of pipeline products.
Sarcopenia Pipeline Market, by Targets
For more target insights, download a free report sample
Key MoA in the Sarcopenia Pipeline Market
The key MoA in the sarcopenia pipeline market are Androgen Receptor Agonist, Chloride Channel Protein 1 Blocker, Glucagon Like Peptide 1 Receptor Agonist, Growth/Differentiation Factor 8 Inhibitor, Indoleamine 2,3 Dioxygenase 1 Inhibitor, and Leucine Rich Repeat Containing G Protein Coupled Receptor 4 Agonist. Androgen Receptor Agonist has the highest number of pipeline products.
Sarcopenia Pipeline Market, by MoA
For more MoA insights, download a free report sample
Key RoA in the Sarcopenia Pipeline Market
The key RoA in the sarcopenia pipeline market are oral, intravenous, topical, and subcutaneous. Oral has the highest number of pipeline products.
Sarcopenia Pipeline Market, by RoA
For more RoA insights, download a free report sample
Key Molecule Type in the Sarcopenia Pipeline Market
The key molecule type in the sarcopenia pipeline market are small molecule, recombinant protein, biologic, cell therapy, fusion protein, gene therapy, antibody, and peptide. Small molecule has the highest number of pipeline products.
Sarcopenia Pipeline Market, by Molecule Type
For more molecule type insights, download a free report sample
Key Companies in the Sarcopenia Pipeline Market
The key companies in the sarcopenia pipeline market are KSbitugen Co Ltd, Keren Therapeutics, Oncocross Co Ltd, Bioleaders Corp, AAVogen Inc, Anagenesis Biotechnologies SAS, ARMGO Pharma Inc, Berg LLC, and Biophytis SA. KSbitugen Co Ltd has the highest number of pipeline products.
Sarcopenia Pipeline Market, by Companies
To know more about companies, download a free report sample
Market report overview
| Key targets | Androgen Receptor, Chloride Channel Protein, Glucagon Like Peptide 1 Receptor, Growth/Differentiation Factor, Indoleamine 2,3 Dioxygenase, and Leucine Rich Repeat Containing G Protein Coupled Receptor 4 |
| Key MoA | Androgen Receptor Agonist, Chloride Channel Protein 1 Blocker, Glucagon Like Peptide 1 Receptor Agonist, Growth/Differentiation Factor 8 Inhibitor, Indoleamine 2,3 Dioxygenase 1 Inhibitor, and Leucine Rich Repeat Containing G Protein Coupled Receptor 4 Agonist |
| Key RoA | Oral, Intravenous, Topical, and Subcutaneous |
| Key molecule types | Small Molecule, Recombinant Protein, Biologic, Cell Therapy, Fusion Protein, Gene Therapy, Antibody, and Peptide |
| Key companies | KSbitugen Co Ltd, Keren Therapeutics, Oncocross Co Ltd, Bioleaders Corp, AAVogen Inc, Anagenesis Biotechnologies SAS, ARMGO Pharma Inc, Berg LLC, and Biophytis SA |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Sarcopenia (Musculoskeletal Disorders).
- The pipeline guide reviews pipeline therapeutics for Sarcopenia (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Sarcopenia (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Sarcopenia (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Sarcopenia (Musculoskeletal Disorders)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Sarcopenia (Musculoskeletal Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Sarcopenia (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Anagenesis Biotechnologies SAS
ARMGO Pharma Inc
Berg LLC
Bioleaders Corp
Biophytis SA
Daewoong Pharmaceutical Co Ltd
Dystrogen Therapeutics SA
Elevian Inc
Elixir Pharma Co Ltd
Encell Co Ltd
Faraday Pharmaceuticals Inc
Gerologix Inc
Helixmith Co Ltd
Juvena Therapeutics Inc
Keren Therapeutics
Klotho Therapeutics Inc
KSbitugen Co Ltd
Lipocine Inc
MedAvail Holdings Inc
MyMD Pharmaceuticals, Inc
Neurotune AG
NMD Pharma AS
Oncocross Co Ltd
OPKO Health Inc
Pephexia Therapeutics ApS
PhaseBio Pharmaceuticals Inc
PRG S&Tech Inc
Ridgeline Therapeutics LLC
ST Pharm Co Ltd
Vibe Pharmaceuticals LLC
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the sarcopenia pipeline market?
The key targets in the sarcopenia pipeline market are Androgen Receptor, Chloride Channel Protein, Glucagon Like Peptide 1 Receptor, Growth/Differentiation Factor, Indoleamine 2,3 Dioxygenase, and Leucine Rich Repeat Containing G Protein Coupled Receptor 4.
-
What are the key MoA in the sarcopenia pipeline market?
The key MoA in the sarcopenia pipeline market are Androgen Receptor Agonist, Chloride Channel Protein 1 Blocker, Glucagon Like Peptide 1 Receptor Agonist, Growth/Differentiation Factor 8 Inhibitor, Indoleamine 2,3 Dioxygenase 1 Inhibitor, and Leucine Rich Repeat Containing G Protein Coupled Receptor 4 Agonist.
-
What are the key RoA in the sarcopenia pipeline market?
The key RoA in the sarcopenia pipeline market are oral, intravenous, topical, and subcutaneous.
-
What are the key molecule type in the sarcopenia pipeline market?
The key molecule type in the sarcopenia pipeline market are small molecule, recombinant protein, biologic, cell therapy, fusion protein, gene therapy, antibody, and peptide.
-
What are the key companies in the sarcopenia pipeline market?
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
Sarcopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Musculoskeletal Disorders reports